Connect with us

Health Care

SGInnovate, SingHealth Partner to Boost AI Adoption in Healthcare

Published

on

SingHealth and Singapore Innovate have signed a three-year partnership to advance the development and adoption of artificial intelligence and other emerging technologies to enhance diagnostics, treatment, healthcare delivery and clinical outcomes on the island city-state.

According to a press statement, SingHealth will combine its extensive clinical research capabilities and pool of clinicians and healthcare innovators with SGInnovate’s expertise in deep technologies and a diverse community of corporates, startups and innovators.

WHAT IT’S ABOUT

They will focus on three main areas: advancing AI thought leadership; supporting the growth and innovation of startups in health and biomedical sciences; and building a health innovation talent pool.

To nurture AI thought leadership, a Community of Practice will be set up that regularly connects both organisations’ networks. This includes quarterly AI and Digital Innovation Journal Clubs and a yearly AI in Health workshop.

Education and engagement initiatives, such as panels, roundtables and reverse pitches, will be promoted to support the startups’ growth and innovations. In particular, the reverse pitches will provide a platform where clinicians and healthcare leaders can present to technology startups their disease and clinical workflow innovation needs. The partners will also identify “technically and clinically robust” AI health initiatives and connect them to strategic collaborators in the industry.

Moreover, they will also work with various biomedical ecosystem stakeholders, including venture capitalists and multinational firms, to develop on-the-job training opportunities for talents.

WHY IT MATTERS

SingHealth Group CEO Ivy Ng noted that the adoption of new healthcare technologies such as AI is “critical for the future of medicine” in order to optimise resources and ensure a robust healthcare system that responds to the evolving patient needs.

SGInnovate CEO Dr Lim Jui also mentioned that there is “much more” to be done to turn the breakthroughs in healthcare and biomedical sciences research into “impactful solutions”.

THE LARGER TREND

Singapore has seen several initiatives around AI in healthcare recently. A chatbot called Doctor COVID enables its healthcare system to better monitor the conditions of migrant workers infected with COVID-19 at community care facilities by speaking to them in their languages.

The Changi General Hospital and the Integrated Health Information Systems have built a deep-learning system that estimates the likelihood of a patient to develop severe pneumonia based on an automated chest x-ray assessment.

Another tool called SELENA+ (Singapore Eye Lesion Analyser Plus) is an AI system that uses retina images to spot eye diseases. Developed by a research team from the Singapore National Eye Centre, Singapore Eye Research Institute and NUS School of Computing, it has been rolled out to about 20 polyclinics in the city-state.

ON THE RECORD

“With the breadth and depth of SingHealth’s clinical capabilities and patient data, we aim to synergise with SGInnovate’s access to deep tech communities and resources to develop innovative solutions that improve care delivery and clinical outcomes. This new partnership will be strategic in equipping our healthcare innovators to advance AI in health and catalyse the process of translating novel ideas from bench to bedside,” SingHealth’s Ng said.

“Working with SingHealth to create partnership and innovation opportunities for biomedical startups is part of SGInnovate’s mission to grow Singapore’s deep tech economy and advance our smart nation ambitions while reinforcing our position as a global centre of excellence for health innovation,” Dr Jui of SGInnovate also commented.

“This partnership will combine the unique strengths of SingHealth and SGInnovate to harness the vast potential in technology and innovation. And indeed, we are at the cusp of a revolution in healthcare technology,” Ong Ye Kung, Singapore’s health minister, also said during the signing of the memorandum of understanding.

Original Source: healthcareitnews.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health Care

Apple Sues NSO Group, Accusing It of Spying on Users in New Lawsuit

Published

on

Apple announced this week that it was suing NSO Group, an Israeli surveillance technology company, in federal court for allegedly accessing users’ devices without authorization.

In addition to damages, the tech giant is seeking to block NSO Group from accessing or using any Apple products, or developing spyware that could be used on Apple products in the future.

“State-sponsored actors like the NSO Group spend millions of dollars on sophisticated surveillance technologies without effective accountability,” said Craig Federighi, Apple’s senior vice president of software engineering, in a statement. “That needs to change.”

Apple devices are “the most secure consumer hardware on the market,” he contended, but “private companies developing state-sponsored spyware have become even more dangerous.

“While these cybersecurity threats only impact a very small number of our customers, we take any attack on our users very seriously, and we’re constantly working to strengthen the security and privacy protections in iOS to keep all our users safe,” Federighi added.

NSO Group offered a statement to Healthcare IT News in response to requests for comment.

“Thousands of lives were saved around the world thanks to NSO Group’s technologies used by its customers,” said NSO Group representatives. “Pedophiles and terrorists can freely operate in technological safe-havens, and we provide governments the lawful tools to fight it. NSO Group will continue to advocate for the truth.”

WHY IT MATTERS

NSO Group says its surveillance technology is used by government intelligence and law enforcement agencies to track criminals.

But as Apple outlines in its complaint, the company’s spyware has reportedly been used against journalists, human rights activists, dissidents, public officials and others.

This month, the U.S. Department of Commerce included the NSO Group in its Entity List for “engaging in activities that are contrary to the national security or foreign policy interests of the United States.” Specifically, the agency said that NSO Group had enabled foreign governments, via its spyware, to “maliciously target” individuals such as embassy workers and academics and to “conduct transnational repression.”

In its complaint, Apple zeroed in on “FORCEDENTRY,” an exploit for a vulnerability used to break into a victim’s device and install NSO Group’s Pegasus spyware product.

The company accused attackers of creating Apple IDs to send malicious data to a victim’s device, which then allowed NSO Group or its clients to surreptitiously deliver Pegasus.

“On information and belief, Defendants provide consulting and expert services to their clients, assist them with their deployment and use of Pegasus, and participate in their attacks on Apple devices, servers and users,” according to the complaint. Although Apple has not observed any evidence of successful remote attacks against devices running iOS 15 or later, it said that each attack carries substantial costs for the company, including the necessity to redirect resources.

“In the meantime, on information and belief, Defendants continue with their pernicious efforts to target and harm Apple and its customers by infecting, exploiting, and misusing Apple devices and software,” said the complaint.

The company also announced that it would be contributing any damages from the lawsuit, plus an extra $10 million, to organizations pursuing cybersurveillance research and advocacy.

“At Apple, we are always working to defend our users against even the most complex cyberattacks,” said Ivan Krstic, head of Apple Security Engineering and Architecture, in a statement.

“The steps we’re taking today will send a clear message: In a free society, it is unacceptable to weaponize powerful state-sponsored spyware against those who seek to make the world a better place.”

THE LARGER TREND

Nation-states have increasingly relied on sophisticated software to carry out governmental objectives.

As Errol Weiss, H-ISAC chief security officer, pointed out in an interview with Healthcare IT News earlier this month, cyber-offensive capabilities have now become the norm, not the exception.

“A few years ago, you could count maybe a few dozen countries that had a decent, offensive cyber capability. And now it’s probably the opposite,” he said. The U.S. government has raised the alarm about these developments, most recently regarding an Iran-sponsored hacker group targeting healthcare.

ON THE RECORD

“Our threat intelligence and engineering teams work around the clock to analyze new threats, rapidly patch vulnerabilities, and develop industry-leading new protections in our software and silicon,” said Apple’s Krstic in a statement.

“Apple runs one of the most sophisticated security engineering operations in the world, and we will continue to work tirelessly to protect our users from abusive state-sponsored actors like NSO Group,” he said.

Kat Jercich is senior editor of Healthcare IT News.
Twitter: @kjercich
Email: kjercich@himss.org
Healthcare IT News is a HIMSS Media publication.

Article: healthcareitnews.com

Continue Reading

Health Care

French Researchers Reveal Chatbot Skills to Override Vaccine Hesitancy

Published

on

A team of French cognitive scientists has addressed the urgent issue of vaccine hesitancy within many EU countries and proposes a new approach. With a study published in October this year, the researchers successfully demonstrated that the reluctance to be vaccinated could be decreased by deploying chatbot technology.

WHY IT MATTERS

The chatbot study involved researchers from the Centre National de la Recherche Scientifique (CNRS), the French National Institute of Health and Medical Research INSERM and ENS-PSL.

The study, published in the Journal of Experimental Psychology: Applied, found that interaction with a chatbot developed by CNRS, ENS-PSL and INSERM was able to reduce vaccination refusal by 20 per cent within a test group of 338 participants.

In the control group, which received only brief information about the COVID-19 vaccination, there were no comparable results in terms of general views and willingness to vaccinate.

THE LARGER TREND

Although nearly three-quarters of all adult Europeans are now fully vaccinated against COVID-19, there remain huge disparities in vaccination rates across countries.

According to the vaccine tracker of the European Centre for Disease Prevention and Control (ECDC) as of 25 November 2021, individual EU countries such as Portugal (81.5 per cent), Ireland (76.2 per cent) and Denmark (76 per cent) have already made great progress in immunising their populations with a full COVID-19 vaccination, while the vaccination rate of other countries such as Germany, France or Austria continues to stagnate at below 70 per cent.

In other parts of Europe, especially in the south-west, the vaccination rates are significantly lower than 50 per cent. In Slovakia (45.7 per cent), Romania (37.3 per cent) and Bulgaria (24.7 per cent), very few people have received the double COVID-19 vaccine dose.

These vaccination backlogs are not only due to vaccine shortages, but in many cases a result of existing scepticism of many Europeans.

The researchers from France now hope that technology-based communication, such as chatbots, could have a positive impact on these figures in the future.

ON THE RECORD

“It remains to be shown whether the effects of chatbot interaction are lasting, and whether they are the same across age groups, and among those most resistant to vaccination”, emphasised the authors of the study with predominantly young and well-educated participants.

They added: “Half of the experimental group later tried to persuade others to get vaccinated, with three-quarters of them stating they drew information provided by the chatbot to do so.”

Source: healthcareitnews.com

Continue Reading

Health Care

Roundup: Medanta Adopts Qure.ai’s X-ray Software, India to Open a Medical Cobotics Centre, and More Briefs

Published

on

Medanta taps Qure.ai for AI-driven chest x-ray analysis

Medanta, a multi-speciality medical group in India, has partnered with Qure.ai to implement the latter’s artificial intelligence software to enhance chest x-ray analysis.

The hospital group will be adopting the qXR software which automatically analyses chest x-rays and spots findings for better diagnosis and treatment. The AI tool can detect 30 abnormalities of the lungs, pleura, heart, bones and diaphragm.

“Medanta strives to deliver world-class healthcare through its high-end medical equipment and superior infrastructure. State-of-the-art technology is an essential aspect of healthcare delivery,” Dr Naresh Trehan, chairman and managing director of Medanta, was quoted as saying in a news report.

The Qure.ai software has also been adopted by Fujifilm Corporation for its portable X-ray FDR Xair system. Through its recent partnership with AstraZeneca Malaysia, the startup has brought its x-ray software to some primary care clinics in Malaysia to support the early detection of lung cancer there.

Medical cobotics centre to be launched in India

The I-Hub Foundation for Cobotics at the Indian Institute of Technology – Delhi (IIT Delhi) and iHub Anubhuti at the Indraprastha Institute of Information Technology – Delhi (IIITD) have signed a memorandum of understanding to set up India’s first medical cobotics centre.

The two government-backed university technology hubs have been developing advanced technologies in robotics and collaborative robots (cobotics), digital health, sensing and computing technologies for robotic-assisted surgeries, training, and medical procedures.

According to a press statement, the Medical Cobotics Centre (MCC) at IIITD will be a tech-enabled medical simulation and training facility for young resident doctors, as well as other healthcare professionals, paramedical staff, technicians, engineers, and researchers.

It will also serve as a validation centre for research outcomes in the area of healthcare cobotics and digital health. This upcoming facility will establish partnerships with companies, undertake research, and work toward the commercialisation of technologies.

MMC’s training programmes will be at multiple levels and cohort-specific, such as urology, neurology, and laparoscopy, but will be initially limited to minimally invasive surgeries. Experts from All India Institute of Medical Sciences in New Delhi and other medical colleges will be consulted for these programmes and invited as guest faculty to conduct them.

The first batch of trainees is targeted to be inducted around April-May next year. They will be initially trained with basic training simulators while advanced surgical robots will come in the next phase.

Moreover, the centre will also be a place for various technology innovation hubs under the Indian government’s National Mission on Interdisciplinary Cyber-Physical Systems to “showcase their medical-related projects and products with applications,” according to IHFC CEO Ashutosh Dutt Sharm and IHFC Project Director Subir Kumar Saha.

Philips Foundation backs cardiac rehab programme in Singapore

Philips Foundation is funding one of the centres run by social service agency Singapore Heart Foundation that provides subsidised cardiac rehabilitation services.

The year-long project of Royal Philips’ non-profit organisation aims to reduce the mortality rate of cardiac incidences and help lower a patient’s risk of hospital readmission.

Specifically, it intends to close the gap in patients’ lack of participation in rehab programmes, which is considered a huge barrier in the secondary prevention of heart diseases. It was reported that only between 6%-15% of Singaporean patients attend cardiac rehabilitation programmes.

SHF-Philips Foundation Heart Wellness Centre is one of the social services’ three centres that provide cardiac patients and at-risk individuals with access to heart health.

Philips’ support, according to SHF Heart Wellness Centres Chairman Dr Tan Yong Seng, will provide SHF with the “resources required to continue providing affordable and quality support to the patients in need, as well as give our team the capacity to focus on raising awareness on the importance of cardiac rehab[ilitation] and drive higher participation in our programmes”.

Under the partnership, 20 sites in Singapore will be equipped with the Philips HeartStart automated external defibrillators (AED) and 500 persons will be trained in giving cardiopulmonary resuscitation (CPR) and AED over a year.

“Through the heart wellness centre’s education initiatives, the AED roll-out and the CPR training, we want to equip individuals and communities with the knowledge and resources to reduce the mortality rates of cardiac incidences in Singapore,” Philips Singapore Country Manager Ivy Lai said.

Original Source: healthcareitnews.com

Continue Reading

Trending

RLER.com